Public offerings of common stock often lead to a decrease in share price due to the dilution of existing shares. Given that NRX Pharmaceuticals has announced such an offering, it is likely that this news has directly contributed to the observed decrease in its share price. The relevance is high as the news directly pertains to NRXP, and the importance is significant for investors considering the potential dilution of their holdings.